These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16113841)

  • 1. Four cases of venous thrombosis in athletes with silent hereditary defects of the protein C system.
    De Caterina M; Grimaldi E; Passaretti M; Ruocco A; Selvetella L; Cavallaro V; Di Biase S; Scopacasa F
    Thromb Haemost; 2005 Aug; 94(2):463-4. PubMed ID: 16113841
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutations at the activated protein C cleavage sites Arg336 and Arg562 of factor VIII in Thai patients with venous thrombosis.
    Prayoonwiwat W; Arnutti P; Nathalang O; Suwanasophon C; Viputtigul K
    Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):880-3. PubMed ID: 12041568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multiple osteonecroses and venous thrombosis: one case of patient with a novel mutation of protein C (N102S) and heterozygous for FV Leiden].
    Benbih M; de Maistre E; Lecompte T; Mainard D; Laprevote MC; Alhenc-Gelas M; Devignes J
    Ann Biol Clin (Paris); 2008; 66(4):437-40. PubMed ID: 18725346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor V Leiden and prothrombin G20210A mutations in Thai patients awaiting kidney transplant.
    Arnutti P; Nathalang O; Cowawintaweewat S; Prayoonwiwat W; Choovichian P
    Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):869-71. PubMed ID: 12757241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
    Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
    Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic determinants of hereditary thrombophilia in pathogenesis of venous thrombosis].
    Kapustin SI; Blinov MN; Kargin VD; Filanovskaia LI; Saltykova NB; Beliazo OE; Golovina OG; Shmeleva VM; Panshina AM; Papaian LP
    Ter Arkh; 2003; 75(10):78-80. PubMed ID: 14669613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor V Leiden, prothrombin G20210A, and protein C mutation frequency in Turkish venous thrombosis patients.
    Altinisik J; Ates O; Ulutin T; Cengiz M; Buyru N
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):415-20. PubMed ID: 18160601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G; Valverde S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplex PCR-RFLP assay for detection of factor V Leiden and prothrombin G20210A.
    Baris I; Koksal V; Etlik O
    Genet Test; 2004; 8(4):381-3. PubMed ID: 15684866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic complications during cancer treatment in children.
    Lipay NV; Dmitriev VV; Borisenok MB
    Exp Oncol; 2007 Sep; 29(3):231-35. PubMed ID: 18004248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor V Kuwait alias factor V R3: a rare polymorphism of uncertain functional significance.
    Castoldi E; Lunghi B; Rosing J; Bernardi F
    Med Princ Pract; 2007; 16(3):244-5; author reply 246. PubMed ID: 17409764
    [No Abstract]   [Full Text] [Related]  

  • 12. Polymorphisms in the protein C gene as risk factor for venous thrombosis.
    Pomp ER; Doggen CJ; Vos HL; Reitsma PH; Rosendaal FR
    Thromb Haemost; 2009 Jan; 101(1):62-7. PubMed ID: 19132190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
    Procare-GEHT Group
    Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cerebral venous thrombosis and factor V Leiden mutation].
    Meng Q; Pu C
    Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(1):47-9. PubMed ID: 11953127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden.
    Morelli VM; De Visser MC; Vos HL; Bertina RM; Rosendaal FR
    J Thromb Haemost; 2005 Jan; 3(1):183-5. PubMed ID: 15634288
    [No Abstract]   [Full Text] [Related]  

  • 16. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
    Dölek B; Eraslan S; Eroğlu S; Kesim BE; Ulutin T; Yalçiner A; Laleli YR; Gözükirmizi N
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V gene A4070G mutation and the risk of cerebral veno-sinus thrombosis occurring during puerperium.
    Dindagur N; Kruthika-Vinod TP; Christopher R
    Thromb Res; 2007; 119(4):497-500. PubMed ID: 16781765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do heterozygous factor V Leiden and prothrombin G20210A mutations have different impact on the type and location of venous thromboembolism?
    Chevalier Y; Mandrillon G; Bestion A; Lega JC; Piquet P; Ninet J; Dargaud Y
    Int Angiol; 2014 Aug; 33(4):404-5. PubMed ID: 25056173
    [No Abstract]   [Full Text] [Related]  

  • 20. Three novel variants in the coagulation factor V gene associated with deep venous thrombosis in Chilean patients with Amerindian ethnic background.
    Guzmán N; Larama G; Ávila A; Salazar LA
    Clin Chim Acta; 2015 Apr; 444():24-8. PubMed ID: 25668227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.